Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 150
- News
MGC Pharmaceuticals Says It May Need A Further Capital Raise As Losses Grow
MGC Pharmaceuticals (MXC) has reported its ‘its strongest half-year result to date’ seeing sales more than triple year-on-year, helping lift its stock price out of an all-time low.
- News
Leafy Tunnel Hopes To Pave The Way For ‘More Institutional Capital’ In European Cannabis Industry
Leafy Tunnel has officially had the first closing of its Guernsey-based investment fund in an important step that it believes will encourage more institutional capital to enter the industry.
- Pharmaceutical
Summerway Capital Returns To AIM To Fund £80m Take-Over Of UK Cannabis Cultivator
SUMMERWAY Capital’s (LON: SWC) £80m reverse takeover of one of the UK’s few licenced high-THC cannabis growers has seen it relaunch its shares on the London Stock Exchange (LSE) in order to fund its new acquisition.
- Markets & Stocks
EU Cannabis Stocks Review: Stenocare Enters UK, Cellular Goods’ Sales Disappoint & Ukraine Crisis Hammers Stocks
The tragic developments in Ukraine hit global markets hard last week, and cannabis stocks even harder.
- Press releases
STENOCARE enters the UK market with three medical cannabis oil products
STENOCARE A/S (“STENOCARE”) to make medical cannabis oil products available for UK patients.
- Press releases
TIKUN EUROPE ANNOUNCES THE ESTABLISHMENT OF TIKUN EUROPE NETHERLANDS BV
TIKUN Europe announces the founding of its subsidiary company, TIKUN Europe Netherlands BV, which will be based in Amsterdam.
- Press releases
Zelira Therapeutics Ltd to acquire Health House
Health House International Limited has signed a binding term sheet with Zelira Therapeutics Ltd for Zelira to acquire Health House
- Pharmaceutical
OCT Board ‘Not At All Concerned’ About Losing Jobs as Co-Founder Calls for Sweeping Removals
Oxford Cannabinoid Technologies (OCT) published its interim results this week reporting ‘good progress’ on all of its key development programmes, but its stock price was dragged down once again following fresh controversy among its board members.
- Pharmaceutical
EU Cannabis Stocks Review: OCT’s Co-Founder Demands Removal Of All 6 Directors – More from Akanda, MGC Pharmaceuticals & Apollon
We start this week’s EU Cannabis Stocks Review with some breaking news from Oxford Cannabinoid Technologies, after the company’s co-founder calls for a general meeting in an attempt enact a dramatic management overhaul.
- Adult-Use
Intercure Makes $35m Acquisition As It Continues International Expansion
Israel’s largest licensed cannabis producer Intercure has announced plans to acquire medical cannabis operator Better for $35m, sending its share prices spiking over 5% for the second time in a week.
- Adult-Use
IM Cannabis Shifts Focus to Organic Growth After Establishing Foothold in Key International Markets
FOLLOWING a whirlwind year of acquisitions, fund raises and a debut on the NASDAQ stock exchange, IM Cannabis (IMC) is now entering the next phase of its lifecycle.
- Adult-Use
EU Cannabis Stocks Review: Intercure Up 10% Amid Positive News From Israel, Ananda’s Progress Met With Share Dip, More From Cannovum, Chill Brands & Yooma Wellness
As markets across Europe continue to be hammered by international tensions, gas price increases and a looming cost of living crisis, cannabis stocks largely struggled to make any significant gains.
